West to Participate in Upcoming Investor Conference
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST) will present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 9:00 am PST in San Francisco.
The presentation will be available via a live webcast accessible in the Investors section of the company website, with a replay available on the website for approximately 90 days after the event.
Positive
- None.
Negative
- None.
The live webcast for this event can be accessed in the Investors section of the Company's website. A replay of this webcast will also be available on the Company's website for approximately 90 days after the event.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conference-302639867.html
SOURCE West Pharmaceutical Services, Inc.